Fight Over Waze? Way
Health Care: Drugs
Merck & Co Inc (MRK: NYSE)
$47.16 -0.17 | -0.36%
05/24/13 - 04:00 PM ET
Portfolios with MRK
- Portfolio NameUser Type
- Userralphd2
- User2013
- ContributorStocks Rising On Unusual Vo...
- UserJeeper Portfolio 1
- UserCapt Jer
- Userlennyvb Portfolio 1
- ContributorDogs of the Dow 2013
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserCovered Calls
Latest MRK Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Haves and Have-Nots 04.17.13 | 08:04 pm
- Cramer Talks Abbott & Glaxo
04.17.13 | 03:04 pm - March Into Merck, Aflac and Nordstrom Shares 04.17.13 | 02:04 pm
- 'Mad Money' Uncovered: Big Pharma on a Down Day in the Market 04.15.13 | 01:04 pm
- Mad Money Uncovered: Merck and the Pharma Laggards 04.15.13 | 12:04 pm
- Merck & Co Inc Stock Buy Recommendation Reiterated (MRK) 04.15.13 | 10:04 am
- Cramer's 'Mad Money' Recap: The Bulls Are In Charge 04.10.13 | 08:04 pm
- Merck & Co Inc (MRK): Health Care's Featured Stock Of The Day 04.10.13 | 05:04 pm
- Cramer's Top Stock Picks: MKC MRK PCLN EXPE TJX 04.10.13 | 06:04 am
- Cramer's 'Mad Money' Recap: As China Goes... 04.09.13 | 08:04 pm
Press Releases for MRK
- Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. - PR Newswire 05.09.13 | 09:05 am
- Merck And Celebrity Chef Art Smith "Cook Up A Recipe" For Better Type 2 Diabetes Management - PR Newswire 05.07.13 | 08:05 am
- Merck Consumer Care Launches Health And Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their Families - PR Newswire 05.06.13 | 09:05 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Merck Announces FDA Acceptance Of Biologics License Application For Investigational Grass Pollen Allergy Immunotherapy Tablet - Business Wire 03.27.13 | 08:03 am
- Merck And Luminex Corporation Enter Agreement To Develop Companion Diagnostic To Support Investigational BACE Inhibitor Clinical Development Program For Alzheimer’s Disease - Business Wire 03.13.13 | 08:03 am
- Results From HPS2-THRIVE Study Of TREDAPTIVE™ (extended-release Niacin/laropiprant) Presented At American College Of Cardiology Scientific Sessions - Business Wire 03.09.13 | 12:03 pm
- Roger M. Perlmutter (Photo: Business Wire) - Business Wire 03.07.13 | 07:03 am
- Merck To Present At The 33rd Annual Cowen Health Care Conference - Business Wire 03.05.13 | 08:03 am
- Merck Announces Second-Quarter 2013 Dividend - Business Wire 02.26.13 | 02:02 pm
Partner Headlines for MRK
- Companies slide $181B through tax loopholes - MSN Money 04.19.13 | 10:04 am
- Revive leadership in pharma R&D - Financial Times 04.17.13 | 08:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,297.25 up 59.39 points - NASDAQ 04.10.13 | 08:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,218.60 down -36.26 points - NASDAQ 04.03.13 | 08:04 pm
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- New foot-and-mouth vaccine developed - Financial Times 03.27.13 | 11:03 pm
- 'Pay For Delay' Case Could Change Generic Drug Rules - Investor's Business Daily 03.26.13 | 04:03 pm
- Common Sense Says Time For Quality, Dividends And Premiums - Seeking Alpha 03.23.13 | 06:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Looking For Bargains And Safety - Seeking Alpha 03.17.13 | 09:03 am
